Lung Cancer Clinical Trials

Showing 1261-1280 of 2,032 trials

Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

NCT04740021

LP002 is a highly selected recombinant humanized anti-PD-L1 monoclonal antibody. This is a single-arm, multicenter study to evaluate the efficacy and safety of LP002 in combination with chemotherapy in patients with extensive stage samll cell lung cancer.

Small-cell Lung Cancer

Taizhou HoudeAoke Biomedical Co., Ltd.46 participantsStarted Dec 2020

Zhengzhou, Henan, China • Changsha, Hunan, China • Wuxi, Jiangsu, China +5 more locations

COMPLETED

Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer

NCT03347825

The main objective of this study is to evaluate and compare peri-operative outcomes of lobectomy compare with different approaches. The study aims to include patients with stage IA, IB, IIA, IIB and IIIA lung cancer that underwent lobectomy via robotic-assisted, VATS and open approach.

Lung Cancer

Intuitive Surgical7,000 participantsStarted Feb 2018

Dallas, Texas, United States

UNKNOWN

Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients

NCT04708639

Circulating tumor DNA can be used to monitor the treatment effect and identify developing resistance mutations during ALK directed TKI treatment.

Lung CancerALK Gene MutationResistance, Disease+1 more

Aarhus University Hospital40 participantsStarted Jun 2019

Aarhus, Denmark

Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer

Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients

Related Searches

A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)

BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Study in Patients With SCLC of Veliparib in Combination With Topotecan

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Magnetic Resonance Imaging for Lung Radiotherapy

Central Nervous System(CNS) Efficacy of Dacomitinib

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer

The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy

A Real-world Study of Durvalumab for Lung Cancer in China

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.